Efficacy and Safety of Intravenous Vernakalant in Rapid Cardioversion of Recent Onset Atrial Fibrillation: A Retrospective Single-Centre Study.

Brinavess (vernakalant) - Merck (MSD), Correvio

http://www.ncbi.nlm.nih.gov/pubmed/38770450

Abbas Hoteit; Acile Nahlawi; Bernard Abi-Saleh; Elsa Hebbo; Farah Abdulhai; Marwan Refaat; Maurice Khoury; Mohamad B Moumneh

May 21, 2024